article thumbnail

Genome Edited Foods: Understanding the New FDA Guidance

XTalks

In a pivotal move for the food industry, the US Food and Drug Administration (FDA) has unveiled industry guidance for genome edited foods derived from plants. This landmark guidance aims to demystify the FDA’s risk-based approach towards both genome edited foods and all new plant varieties. What is Genome Editing?

Genome 86
article thumbnail

Opinion: Where are the guidelines for the production of animals with intentional genomic alterations?

STAT News

Genetic engineering has the potential to transform how we raise animals for meat and other products, making food safer, improving animal health and welfare, and shrinking animal agriculture’s environmental footprint. Pigs that are less likely to induce allergic reactions in humans. Read the rest…

Genome 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Indian medical devices cos to invest in innovation for products minimizing environmental footprint

AuroBlog - Aurous Healthcare Clinical Trials blog

Indian medical devices companies are increasingly looking to invest in innovation for developing products that help to minimize environmental footprint.

article thumbnail

New CRISPR-ready neurons could democratise genomics

Drug Discovery World

bit.bio has launched the first offering from its new product range ioCRISPR-Ready Cells, which allow research and drug discovery scientists to knockout any gene of interest in glutamatergic neurons. ioCells products are reprogrammed from human induced pluripotent stem cells (iPSCs) by opti-ox, bit.bio’s precision cell programming technology.

Genome 52
article thumbnail

Investment fuels AI-driven development of breakthrough genomic medicines

pharmaphorum

David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets. We founded Whitelab Genomics after realising the potential to use data, data science, and AI in a more systematic way to develop genomic therapies,” Del Bourgo says.

Genome 103
article thumbnail

BIO comments on FDA draft guidance for human gene therapy products incorporating human genome editing

BioPharma Reporter

BIO, the worldâs largest trade association for the biotech industry, has responded to the US Food and Drug Administration's draft guidance on developing human gene therapy products that incorporate genome editing (GE) of human somatic cells.

article thumbnail

Novel technique opens up new possibilities in synthetic genomics

Drug Discovery World

Known as ‘CReATiNG’ (Cloning Reprogramming and Assembling Tiled Natural Genomic DNA), the method offers a simpler and more cost-effective approach to constructing synthetic chromosomes. The thing about most synthetic genomics research is that it involves building chromosomes or genomes from scratch using chemically synthesised DNA pieces.

Genome 52